Lhasa Limited shared knowledge shared progress
PublicationsJump to results
Publication Type
Publication Year
Related Products
New search
Investigation of patent and grant data to support purge calculations of DNA reactive (mutagenic) impurities used for risk assessmentJune 2016pdf fileMirabilis
Applicability Domain: Towards a more formal definitionJune 2016pdf file
Developing expert in silico systemsJune 2016pdf fileDerek NexusMeteor Nexus
The use of in silico tools to support expert review under ICH M7June 2016pdf fileDerek NexusSarah Nexus
Mutagenicity Prediction Using In Silico Methods: Gigabyte-Sized Petri DishesJune 2016pdf fileDerek NexusZenethVitic NexusSarah NexusMirabilisMeteor Nexus
Aromatic Amines 2016.1.0 Release Notes.pdfJune 2016pdf fileVitic Nexus
Progress on Building a Tool for Predicting the Purging of Mutagenic Impurities During SynthesisJune 2016Mirabilis
Using In Silico Software to Generate an ICH M7 Submission and Expert ReviewMay 2016pdf file
Lhasa trusted community KNIME nodesMay 2016
Is preclinical data sharing the new norm?May 2016Derek NexusETOXExcipientsIntermediatesMeteor NexusVitic Nexus
Sarah Nexus Mutagenicity QMRF.pdfMay 2016pdf fileSarah Nexus
Medicinal Chemistry is an Art, when you don't understand the dataMay 2016pdf file
Impact from the Recent Issuance of ANVISA Resolution RDC-53/2015 on Pharmaceutical Small Molecule Forced Degradation Study RequirementsMay 2016Zeneth
Using Derek Nexus as part of a skin sensitisation integrated testing strategy (ITS)May 2016Derek Nexus
Using Derek Nexus to assess the safety of raw materials used in cosmeticsMay 2016Derek Nexus
Cheminformatics from end-user perspective: Past, present and futureApril 2016pdf file
Guiding Compound Design in 2,3...N DimensionsApril 2016pdf file
Speeding up and improving the Identification of a potent ß2 agonist as a growth promoter for cattleApril 2016pdf file
Harnessing comprehensive small molecule project data to inform design and decisionsApril 2016pdf file
Effective use of experiment modeling for the capture and analysis of results in DMPK/ADMEApril 2016pdf file
TB Alliance Drug Discovery and Development: Harnessing Global Resources to Address a Global DiseaseApril 2016pdf file
Structure Guided Design and Optimization of Selective Kinase Inhibitors from Fragment Starting PointsApril 2016pdf file
Going from 2D to 3D: The Importance of Visual FeedbackApril 2016pdf file
Practical Implementation of (Q)SAR and Expert Review for Compliance with ICH M7 GuidelinesApril 2016pdf file
Predicting the Purging of Impurities within an API Synthetic PathwayApril 2016pdf file

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.